Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

S1), and seven: Calcifediol, Calcitriol, LDE-225, Lonafarnib, Lovastatin, Sunitinib, and Trametinib: caused substantial increases in 1 kDa NHS Ester permeability (Fig. 3C).

Source: Identification of BBB-opening small molecules. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Zebrafish were maintained at 28.5°C following standard protocols.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

In vivo discovery of blood-brain barrier opening small molecules with FishNAP

Study design awaiting verification · bioRxiv · 2026

Original publication title

In vivo discovery of blood-brain barrier opening small molecules with FishNAP

Thomas C. Potts; Erin E. McDonnell; Lewis G. Gall; Evangeline Coffinas; Jacklyn Levey; Colleen G. Rutley; Neha Gururaj; Alexandra K. Vindigni; Advait R. Iyer; Manan H. Gosai; Megan E. Canace; Natasha M. O’Brown

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The blood: brain barrier (BBB) is crucial for neural homeostasis, tightly regulating molecular exchange between the circulation and brain. However, this selective protection also greatly limits drug delivery to the central nervous system, posing a major challenge for treating neurological disorders. Pharmacological strategies that transiently and safely increase BBB permeability could therefore transform brain drug delivery, yet systematic discovery of such modulators remains hampered by the limitations of current in vitro and in vivo approaches. Here we present FishNAP, a non-invasive, high-throughput zebrafish platform for real-time assessment of BBB permeability in vivo.

FishNAP captures developmental changes in barrier function and detects dysfunction in genetic mutants. Using this platform, we screened 2,320 FDA-approved small molecules for compounds capable of opening an intact BBB and identified 11 that reproducibly increased permeability. Seven of these molecules allowed entry of a 1 kDa tracer into brain tissue, and five also permitted passage of a larger 10 kDa Dextran. Barrier integrity recovered within 24 hours for all seven compounds, indicating reversible modulation. Finally, testing three representative molecules (Calcitriol, Lovastatin, and Sunitinib) in adult mice revealed increased BBB permeability and reduced Claudin- 5 expression, demonstrating conserved mechanisms of BBB-regulation across vertebrates.

FishNAP thus enables systematic discovery of BBB modulators with direct translational potential for brain drug delivery.

Authors’ abstract

The blood: brain barrier (BBB) is crucial for neural homeostasis, tightly regulating molecular exchange between the circulation and brain. However, this selective protection also greatly limits drug delivery to the central nervous system, posing a major challenge for treating neurological disorders. Pharmacological strategies that transiently and safely increase BBB permeability could therefore transform brain drug delivery, yet systematic discovery of such modulators remains hampered by the limitations of current in vitro and in vivo approaches. Here we present FishNAP, a non-invasive, high-throughput zebrafish platform for real-time assessment of BBB permeability in vivo.

FishNAP captures developmental changes in barrier function and detects dysfunction in genetic mutants. Using this platform, we screened 2,320 FDA-approved small molecules for compounds capable of opening an intact BBB and identified 11 that reproducibly increased permeability. Seven of these molecules allowed entry of a 1 kDa tracer into brain tissue, and five also permitted passage of a larger 10 kDa Dextran. Barrier integrity recovered within 24 hours for all seven compounds, indicating reversible modulation. Finally, testing three representative molecules (Calcitriol, Lovastatin, and Sunitinib) in adult mice revealed increased BBB permeability and reduced Claudin- 5 expression, demonstrating conserved mechanisms of BBB-regulation across vertebrates.

FishNAP thus enables systematic discovery of BBB modulators with direct translational potential for brain drug delivery.

Publication and source details

Original title: In vivo discovery of blood-brain barrier opening small molecules with FishNAP

Thomas C. Potts; Erin E. McDonnell; Lewis G. Gall; Evangeline Coffinas; Jacklyn Levey; Colleen G. Rutley; Neha Gururaj; Alexandra K. Vindigni; Advait R. Iyer; Manan H. Gosai; Megan E. Canace; Natasha M. O’Brown

bioRxiv · 2026

* Corresponding author

Author Contribution Statement

More Concise Version:

N.M.O. and T.C.P. developed the concept, experimental design, and wrote the manuscript. C.G.R. contributed to the development of FishNAP. T.C.P., E.E.M., L.G.G., J.L., E.C., N.P., A.K.V., A.R.I., M.H.G. and M.E.C. conducted animal experiments and analyzed data.

https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:01:54.167011+00:00

DOI: 10.64898/2026.03.18.712473 · PMC13015469